203 related articles for article (PubMed ID: 35163412)
41. Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis.
Opavsky MA; Martino T; Rabinovitch M; Penninger J; Richardson C; Petric M; Trinidad C; Butcher L; Chan J; Liu PP
J Clin Invest; 2002 Jun; 109(12):1561-9. PubMed ID: 12070303
[TBL] [Abstract][Full Text] [Related]
42. Cardiac deletion of the Coxsackievirus-adenovirus receptor abolishes Coxsackievirus B3 infection and prevents myocarditis in vivo.
Shi Y; Chen C; Lisewski U; Wrackmeyer U; Radke M; Westermann D; Sauter M; Tschöpe C; Poller W; Klingel K; Gotthardt M
J Am Coll Cardiol; 2009 Apr; 53(14):1219-26. PubMed ID: 19341864
[TBL] [Abstract][Full Text] [Related]
43. IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart.
Fairweather D; Frisancho-Kiss S; Yusung SA; Barrett MA; Davis SE; Steele RA; Gatewood SJ; Rose NR
J Immunol; 2005 Jan; 174(1):261-9. PubMed ID: 15611248
[TBL] [Abstract][Full Text] [Related]
44. IL-21R expression on CD8+ T cells promotes CD8+ T cell activation in coxsackievirus B3 induced myocarditis.
Liu W; Dienz O; Roberts B; Moussawi M; Rincon M; Huber SA
Exp Mol Pathol; 2012 Jun; 92(3):327-33. PubMed ID: 22465422
[TBL] [Abstract][Full Text] [Related]
45. Roles of PAR1 and PAR2 in viral myocarditis.
Mackman N; Antoniak S
Thromb Res; 2014 May; 133 Suppl 1(0 1):S18-20. PubMed ID: 24759133
[TBL] [Abstract][Full Text] [Related]
46. AIM2 Co-immunization with VP1 Is Associated with Increased Memory CD8 T Cells and Mounts Long Lasting Protection against Coxsackievirus B3 Challenge.
Yin L; Chai D; Yue Y; Dong C; Xiong S
Front Cell Infect Microbiol; 2017; 7():247. PubMed ID: 28642849
[TBL] [Abstract][Full Text] [Related]
47. α-Galactosylceramide protects mice from lethal Coxsackievirus B3 infection and subsequent myocarditis.
Wu CY; Feng Y; Qian GC; Wu JH; Luo J; Wang Y; Chen GJ; Guo XK; Wang ZJ
Clin Exp Immunol; 2010 Oct; 162(1):178-87. PubMed ID: 20726989
[TBL] [Abstract][Full Text] [Related]
48. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis.
Henke A; Huber S; Stelzner A; Whitton JL
J Virol; 1995 Nov; 69(11):6720-8. PubMed ID: 7474082
[TBL] [Abstract][Full Text] [Related]
49. Involvement of Endoplasmic Reticulum Stress-Mediated C/EBP Homologous Protein Activation in Coxsackievirus B3-Induced Acute Viral Myocarditis.
Cai Z; Shen L; Ma H; Yang J; Yang D; Chen H; Wei J; Lu Q; Wang DW; Xiang M; Wang J
Circ Heart Fail; 2015 Jul; 8(4):809-18. PubMed ID: 25985795
[TBL] [Abstract][Full Text] [Related]
50. [Protective effect and mechanism of IL-17 monoclonal antibody on mice with viral myocarditis].
Qian H; Liu L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):509-12. PubMed ID: 24796747
[TBL] [Abstract][Full Text] [Related]
51. PAR-1 contributes to the innate immune response during viral infection.
Antoniak S; Owens AP; Baunacke M; Williams JC; Lee RD; Weithäuser A; Sheridan PA; Malz R; Luyendyk JP; Esserman DA; Trejo J; Kirchhofer D; Blaxall BC; Pawlinski R; Beck MA; Rauch U; Mackman N
J Clin Invest; 2013 Mar; 123(3):1310-22. PubMed ID: 23391721
[TBL] [Abstract][Full Text] [Related]
52. Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis.
Henke A; Zell R; Ehrlich G; Stelzner A
J Virol; 2001 Sep; 75(17):8187-94. PubMed ID: 11483764
[TBL] [Abstract][Full Text] [Related]
53. Recombinant Mouse β-Defensin 3 Protects against Coxsackievirus B3-Induced Myocarditis in Mice.
Jiang Y; Zhu R; Luo L; Mu Q; Zhu Y; Luo H; Zou X; Shen X
Intervirology; 2015; 58(6):343-9. PubMed ID: 26829552
[TBL] [Abstract][Full Text] [Related]
54. A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling.
Gui J; Yue Y; Chen R; Xu W; Xiong S
PLoS One; 2012; 7(9):e46515. PubMed ID: 23029542
[TBL] [Abstract][Full Text] [Related]
55. Cell type-specific roles of PAR1 in Coxsackievirus B3 infection.
Bode MF; Schmedes CM; Egnatz GJ; Bharathi V; Hisada YM; Martinez D; Kawano T; Weithauser A; Rosenfeldt L; Rauch U; Palumbo JS; Antoniak S; Mackman N
Sci Rep; 2021 Jul; 11(1):14264. PubMed ID: 34253819
[TBL] [Abstract][Full Text] [Related]
56. Sex differences in coxsackievirus B3-induced myocarditis: IL-12Rbeta1 signaling and IFN-gamma increase inflammation in males independent from STAT4.
Frisancho-Kiss S; Nyland JF; Davis SE; Frisancho JA; Barrett MA; Rose NR; Fairweather D
Brain Res; 2006 Dec; 1126(1):139-47. PubMed ID: 16949558
[TBL] [Abstract][Full Text] [Related]
57. Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas.
Pinkert S; Pryshliak M; Pappritz K; Knoch K; Hazini A; Dieringer B; Schaar K; Dong F; Hinze L; Lin J; Lassner D; Klopfleisch R; Solimena M; Tschöpe C; Kaya Z; El-Shafeey M; Beling A; Kurreck J; Van Linthout S; Klingel K; Fechner H
Cardiovasc Res; 2020 Aug; 116(10):1756-1766. PubMed ID: 31598635
[TBL] [Abstract][Full Text] [Related]
58. Major Group-B Enterovirus populations deleted in the noncoding 5' region of genomic RNA modulate activation of the type I interferon pathway in cardiomyocytes and induce myocarditis.
Callon D; Glenet M; Lebreil AL; Heng L; Bouland N; Fichel C; Fornes P; Andreoletti L; Berri F
PLoS Pathog; 2024 May; 20(5):e1012125. PubMed ID: 38696536
[TBL] [Abstract][Full Text] [Related]
59. Cardiomyocyte-specific deletion of Senp2 contributes to CVB3 viral replication and inflammation.
Wang K; Jiang Z; Lu X; Zhang Y; Yuan X; Luo D; Lin Z; Zuo Y; Luo Q
Int Immunopharmacol; 2020 Nov; 88():106941. PubMed ID: 33182061
[TBL] [Abstract][Full Text] [Related]
60. Coxsackievirus B3 induces apoptosis in the early phase of murine myocarditis: a comparative analysis of cardiovirulent and noncardiovirulent strains.
Joo CH; Hong HN; Kim EO; Im JO; Yoon SY; Ye JS; Moon MS; Kim D; Lee H; Kim YK
Intervirology; 2003; 46(3):135-40. PubMed ID: 12867750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]